Abstract
Gastrointestinal (GI) tract infections are caused by a wide variety of fungi, viruses, and bacteria, and all areas of the GI tract are affected. Infections range from mild, where disease is self-limited and supportive care is the treatment, to severe, where hospitalization and intravenous fluids and antibiotics are required for survival. In recent years, the increasing antibiotic resistance of various bacteria has become an important aspect of GI infection treatment and has resulted in augmentation of therapy.
Keywords
- Sustained Virologic Response
- Hemolytic Uremic Syndrome
- Typhoid Fever
- Thrombotic Thrombocytopenic Purpura
- Spontaneous Bacterial Peritonitis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vazquez JA (2000). Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials 1:47–59
Pace F, Pallotta S, Antinori S (2007). Nongastroesophageal reflux disease-related infectious, inflammatory, and injurious disorders of the esophagus. Curr Opin Gastroenterol 23:446–451
Vazquez JA, Sobel JD (2002). Mucosal candidiasis. Infect Dis Clin N Am 16:793–820
Krause DS, Simjee AE, Rensburg C et al. (2004). A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis 39:770–775
Makola D, Peura DA, Crowe SE (2007). Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 41(6):548–558
Goldberg D, Szilagyi A, Graves L (2007). Hyperemesis gravidarum and Helicobacter pylori infection. Obstet Gynecol 110:695–703
Ramakrishnan K, Salinas R (2007). Peptic ulcer disease. Am Fam Physician 76:1005–1012
Zagari RM, Bianchi-Porro G, Fiocca R et al. (2007). Comparison of 1 and 2 weeks of omeprazole, amoxicillin, and clarithromycin treatment for Helicobacter pylori eradication: The HYPER study. Gut 56:475–479
Zullo A, De Francesco V, Hassan C et al. (2007). The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis. Gut 56:1353–1357
Laesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL (2007). Helicobacter pylori and probiotics. J Nutr 137(3 Suppl 2):812S–818S
Penner R, Fedorak RN, Madsen KL (2005). Probiotics and nutraceuticals: Non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 5:596–603
Grimwood K, Buttery JP (2007). Clinical update: Rotavirus gastroenteritis and its prevention. Lancet 370:302–304
Vesikari T, Matson DO, Dennehy P et al. (2006). Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33
Estes MK, Prasad BV, Atmar RL (2006). Noroviruses everywhere: Has something changed? Curr Opin Infect Dis 19:467–474
CDC (2006). Norovirus: Technical fact sheet. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. (Accessed on Jul 15, 2008 http://www.cdc.gov/ncidod/dvrd/revb/gastro/noro-factsheet.pdf)
Thielman NM, Guerrant RL (2004). Acute infectious diarrhea. N Engl J Med 350:38–47
Gadewar S, Fasano A (2005). Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharm 5:559–565
Ilnyckyj A (2001). Clinical evaluation and management of acute infectious diarrhea in adults. Gastroenterol Clin N Am 30:599–609
Marcos LA, DuPont HL (2007). Advances in defining etiology and new therapeutic approaches in acute diarrhea. J Infect 55:385–393
Yates J (2005). Traveler’s diarrhea. Am Fam Physician 71:2095–2100
Shlim DR (2005). Update in traveler’s diarrhea. Infect Dis Clin N Am 19:137–149
Panoz GZ, Betsi GI, Falagas ME (2006). Systematic review: Are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther 24:731–742
Tarr PI, Gordon CA, Chandler WL (2005). Shiga-toxin-producing Escherichia coli and hemolytic uraemic syndrome. Lancet 365:1073–1086
Todd WTA, Dundas S (2001). The management of VTEC O157 infection. Int J Food Microbiol 66:103–110
Qadri F, Svennerholm A, Faruque ASG, Sack RB (2005). Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 18:465–483
Galanis E (2007). Campylobacter and bacterial gastroenteritis. CMAJ 177:570–571
Gibreel A, Taylor DE (2006). Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 58:243–255
DuPont HL (2007). The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis 45:1352–1361
Moore JE, Barton MD, Blair IS et al. (2006). The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 8:1955–1966
Linam WM, Gerber MA (2007). Changing epidemiology and prevention of Salmonella infections. Pediatr Infect Dis J 26:747–748
Hohmann EL (2001). Nontyphoidal salmonellosis. Clin Infect Dis 32:263–269
Graham SM (2002). Salmonellosis in children in developing and developed countries and populations. Curr Opin Infect Dis 15:507–512
Molbak K (2005). Human health consequences of antimicrobial drug–resistant Salmonella and other foodborne pathogens. Clin Infect Dis 41:1613–1620
Bhutta ZA (2006). Current concepts in the diagnosis and treatment of typhoid fever. BMJ 333:78–82
Luxemburger C, Dutta AK (2005). Overlapping epidemiologies of Hepatitis A and typhoid fever: The needs of the traveler. J Travel Med 12:S12–S21
Sur D, Ramamurthy T, Deen J, Bhattacharya SK (2004). Shigellosis: Challenges & management issues. Indian J Med Res 120:454–462
Zuckerman JN, Rombo L, Fisch A (2007). The true burden and risk of cholera: Implications for prevention and control. Lancet Infect Dis 7:521–530
Sack DA, Sack RB, Nair GB et al. (2004). Cholera. Lancet 363:223–233
Griffith DC, Kelly-Hope LA, Miller MA (2006). Review of reported cholera outbreaks worldwide, 1995–2005. Am J Trop Med Hyg 75:973–977
DeBerardis B, Torresini G, Brucchi M et al. (2004). Yersinia enterocolitica intestinal infection with ileum perforation: Report of a clinical observation. Acta Biomed 75:77–81
Fredriksson-Ahomaa M, Korkeala H (2003). Low occurrence of pathogenic Yersinia enterocolitica in clinical, food, and environmental samples: A methodological problem. Clin Microbiol Rev 6:220–229
Skovgaard N (2007). New trends in emerging pathogens. Int J Food Microbiol 120:217–224
Bottone EJ (1997). Yersinia enterocolitica: The charisma continues. Clin Microbiol Rev 10:257–276
Ehling-Schulz M, Fricker M, Scherer S (2004). Bacillus cereus, the causative agent of an emetic type of food-borne illness. Mol Nutr Food Res 48:479–487
Schlech WF (2003). Foodborne Listeriosis. Clin Infect Dis 31:770–775
Swaminathan B, Gerner-Smidt P (2007). The epidemiology of human listeriosis. Microbes Infect 9:1236–1243
Razavi B, Apisarnthanarak A, Mundy LM (2007). Clostridium difficile: Emergence of hypervirulence and fluoroquinolone resistance. Infection 35:300–307
Crogan NL, Evans BC (2007). Clostridium difficile: An emerging epidemic in nursing homes. Geriatr Nurs 28:161–164
Kuijper EJ, van Dissel JT, Wilcox MH (2007). Clostridium difficile: Changing epidemiology and new treatment options. Curr Opin Infect Dis 20:376–383
Miller MA (2007). Clinical management of Clostridium difficile-associated disease. Clin Infect Dis 45:S122–S128
Balagopal A, Sears CL (2007). Clostridium difficile: New therapeutic options. Curr Opin Pharm 7:455–458
Vesy CJ, Peterson WL (1999). Review article: The management of giardiasis. Aliment Pharmacol Ther 13:843–850
Ali V, Nozaki T (2007). Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by “amitochondriate” protozoan parasites. Clin Microbiol Rev 20:164–187
Huang DB, White AC (2006). An updated review on Cryptosporidium and Giardia. Gastroenterol Clin N Am 35:291–314
Dominguez EP, Sweeney JF, Choi YU (2006). Diagnosis and management of diverticulitis and appendicitis. Gastroenterol Clin N Am 35:367–391
Jacobs DO (2007). Diverticulitis. N Engl J Med 357:2057–2066
Uronis HE, Bendell JC (2007). Anal cancer: An overview. Oncologist 12:524–534
Palefsky J (2006). Human papillomavirus-related tumors in HIV. Curr Opin Oncol 18:463–468
Stanley M (2007). Prophylactic HPV vaccines: Prospects for eliminating ano-genital cancer. Br J Cancer 96:1320–1323
Andoh A, Fujiyama Y (2006). Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J Gastroenterol 12:4452–4460
Perencevich M, Burakoff R (2006). Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 12:651–664
Gionchetti P, Rizzello F, Lammers KM et al. (2006). Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306–3313
Hecht GA (2008). Inflammatory bowel disease – live transmission. N Engl J Med 358: 528–530
Kozuch PL, Hanauer SB (2008). Treatment of inflammatory bowel disease: A review of medical therapy. World J Gastroenterol 14:354–377
Brundage SC, Fitzpatrick AN (2006). Hepatitis A. Am Fam Physician 73:2162–2168
Wilson TR (2005). The ABCs of hepatitis. Nurse Pract 30:12–21
Zuckerman JN (2006). Vaccination against hepatitis A and B: Developments, deployment, and delusions. Curr Opin Infect Dis 19:456–459
Lin KW, Kirchner JT (2004). Hepatitis B. Am Fam Physician 69:75–82, 86
Stribling R, Sussman N, Vierling JM (2006). Treatment of hepatitis C infection. Gastroenterol Clin N Am 35:463–486
Brusaferro S, Barbone F, Andrian P et al. (1999). A study on the role of the family and other risk factors in HCV transmission. Eur J Epidemiol 15:125–132
Isaguliants MG (2007). Functionality of the immune system in patients with chronic hepatitis C: Trial by superinfections and vaccinations. Expert Rev Vaccines 6:527–537
Tan J, Lok ASF (2006). Update on viral hepatitis: 2006. Curr Opin Gastroenterol 23:263–267
Rosenberg PM (2001). Hepatitis C: A hepatologist’s approach to an infectious disease. Clin Inf Dis 33:1728–1732
Bacon BR, McHutchinson JG (2007). Into the light: Strategies for battling hepatitis C. Am J Manag Care 13:S319–S326
Emerson SU, Purcell RH (2007). Hepatitis E. Pediatr Infect Dis J 26:1147–1148
Jaroszewicz J, Flisiak R, Kalinowska A et al. (2005). Acute hepatitis E complicated by acute pancreatitis: A case report and literature review. Pancreas 30:382–384
Kuiper JJ, van Buuren HR, de Man RA (2007). Ascites in cirrhosis: A review of management and complications. Neth J Med 65:283–288
Heidelbaugh JJ, Sherbondy M (2006). Cirrhosis and chronic liver failure: Part II. Complications and treatment. Am Fam Physician 74:767–777
Koulaouzidis A, Bhat S, Karagiannidis A et al. (2007). Spontaneous bacterial peritonitis. Postgrad Med J 83:379–383
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Post, R.E., Hainer, B.L. (2010). Gastrointestinal Tract Infections. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-60327-239-1_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-238-4
Online ISBN: 978-1-60327-239-1
eBook Packages: MedicineMedicine (R0)